American Psychological Association 6th edition

Denicolò S, Nair V, Leierer J, Rudnicki M, Kretzler M, Mayer G, Ju W, & Perco P. (2022). Assessment of Fibrinogen-like 2 (FGL2) in Human Chronic Kidney Disease through Transcriptomics Data Analysis. Biomolecules, 13(1). https://doi.org/10.3390/biom13010089

ISO-690 (author-date, English)

DENICOLÒ S, NAIR V, LEIERER J, RUDNICKI M, KRETZLER M, MAYER G, JU W und PERCO P, 2022. Assessment of Fibrinogen-like 2 (FGL2) in Human Chronic Kidney Disease through Transcriptomics Data Analysis. Biomolecules. 31 Dezember 2022. Vol. 13, no. 1, . DOI 10.3390/biom13010089.

Modern Language Association 9th edition

Denicolò S, Nair V, Leierer J, Rudnicki M, Kretzler M, Mayer G, Ju W, und Perco P. „Assessment of Fibrinogen-Like 2 (FGL2) in Human Chronic Kidney Disease through Transcriptomics Data Analysis.“. Biomolecules, Bd. 13, Nr. 1, Dezember 2022, https://doi.org/10.3390/biom13010089.

Mohr Siebeck - Recht (Deutsch - Österreich)

Denicolò S/Nair V/Leierer J/Rudnicki M/Kretzler M/Mayer G u. a.: Assessment of Fibrinogen-like 2 (FGL2) in Human Chronic Kidney Disease through Transcriptomics Data Analysis., Biomolecules 2022,

Emerald - Harvard

Denicolò S, Nair V, Leierer J, Rudnicki M, Kretzler M, Mayer G, Ju W und Perco P. (2022), „Assessment of Fibrinogen-like 2 (FGL2) in Human Chronic Kidney Disease through Transcriptomics Data Analysis.“, Biomolecules, Vol. 13 No. 1, verfügbar unter:https://doi.org/10.3390/biom13010089.

Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.